By regulating downstream signaling pathways, mainly the PI3K/Akt and MAPK, the activated EGFR led to receptor dimerization and tyrosine autophosphorylation which could result in aberrant proliferation in certain cells, such as NSCLC cells [55]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.